Science Current Events | Science News |

Research findings reveal potential to reverse cancer-related nerve pain

May 09, 2016

A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.

The study in rats showed transfer of a gene known as KCC2 into the spinal canal restored chloride levels gone awry after nerve injury. Results from the research at The University of Texas MD Anderson Cancer Center, were published in the May 5 online issue of Cell Reports.

The results also could have implications for treatment of chronic pain due to diabetic neuropathy and spinal cord injury since neuropathic pain caused by these conditions is associated with reduced KCC2 activity.

"We found that delivery of KCC2 produced a complete and long-lasting reversal of nerve injury-induced pain hypersensitivity by restoring chloride homeostasis," said Hui-Lin Pan, M.D., Ph.D., professor of Anesthesiology and Perioperative Medicine. "This information significantly advances our understanding of these processes and provides a promising gene therapy strategy for treating unmanageable neuropathic pain."

The proper balance of chloride, a mineral crucial for nerve cell function, is thrown off kilter by nerve damage associated with surgery or the toxic aspects of standard chemotherapies. This causes the inhibitory neurotransmitters GABA and glycine to become less effective and increases activity by excitatory nerve receptors known as NMDA receptors.

"Diminished synaptic inhibition by GABA and glycine and increased NMDA receptor activity are two key mechanisms underlying neuropathic pain," said Pan. "However the reciprocal relationship between the two is unclear. By using KCC2 gene transfer, we were able to restore chloride balance which also unexpectedly normalized NMDA receptor activity increased by nerve injury."

Chronic neuropathic pain is a major, debilitating clinical challenge that is difficult to treat. Existing analgesics including anti-depressants, opioids and gabapentinoids have limited efficacy and often produce intolerable side effects.

"The development of highly effective patient treatments with minimal effects is urgently needed," said Pan. "Our study addressed the need to change the intracellular concentration of chloride which can profoundly alter the strength and polarity of GABA and glycine."

Pan's study provided direct evidence that disrupted chloride homeostasis plays a critical role in regulation of NMDA receptors in neuropathic pain and that nerve injury increases NMDA receptor activity in the spinal cord by disrupting chloride levels.


Study team members included Linyong Li, Ph.D., Shao-Rui Chen, M.D., Lei Wen, Ph.D. and Jing-Dun Xie, M.D., all of Anesthesiology and Perioperative Medicine; and Walter Hittleman, Ph.D., Experimental Therapeutics.

The study was funded by the National Institutes of Health (RO1 NS073935 and R01 DE022015) and the N.G. and Helen T. Hawkins Distinguished Professorship for Cancer Research.

University of Texas M. D. Anderson Cancer Center

Related Neuropathic Pain Current Events and Neuropathic Pain News Articles

Drug used for pain, anxiety may be linked to birth defects
A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology¨, the medical journal of the American Academy of Neurology.

Tarantula toxins converted to painkillers
When venom from animals such as spiders, snakes or cone snails is injected via a bite or harpoon, the cocktail of toxins delivered to its victim tends to cause serious reactions that, if untreated, can be lethal. But even venom has a therapeutic upside: Individual peptide toxins are being tapped to target receptors in the brain to potentially serve as painkillers.

Energy from cellphone towers amplify pain in amputees, UT Dallas study finds
For years, retired Maj. David Underwood has noticed that whenever he drove under power lines and around other electromagnetic fields, he would feel a buzz in what remained of his arm. When traveling by car through Texas' open spaces, the buzz often became more powerful.

Receptors inside nerve cells may be a key to controlling pain
In real estate, location is key. It now seems the same concept holds true when it comes to stopping pain.

Patients who are not prescribed opioids find more improvements in physical function, study
Opioids such as morphine, codeine and Tylenol 3 can be effective for treating pain, however, a new University of Alberta study finds that patients with neuropathic pain taking opioids report no improvements in physical functioning compared to those who were not prescribed opioids.

Magnetic stimulation of the brain may help patients with cocaine addiction
Targeted magnetic pulses to the brain were shown to reduce craving and substance use in cocaine-addicted patients.

Standard phenotypes will aid in genetic research on neuropathic pain
Research on the genetic factors contributing to neuropathic pain has been hindered by the lack of a standard approach to assessing its clinical characteristics or "phenotype."

Pain is in the brain
Chronic pain results from disease or trauma to the nervous system. Damaged nerve fibres with heightened responses to normal stimuli send incorrect messages to pain centres in the brain.

Brain plasticity in the most dreaded biblical disease
Brain plasticity is the ability of the brain to change both anatomically and functionally in response to changes in the body or in the environment.

Antidepressants fine-tune brain reward pathway to lessen neuropathic pain
Commonly used antidepressant drugs change levels of a key signaling protein in the brain region that processes both pain and mood, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published August 24 in the Proceedings of the National Academy of Sciences (PNAS).
More Neuropathic Pain Current Events and Neuropathic Pain News Articles

Neuropathic Pain: Causes, Management and Understanding

Neuropathic Pain: Causes, Management and Understanding
by Cory Toth (Editor), Dwight E. Moulin (Editor)

Central or peripheral neuropathic pain can be caused by a wide range of injuries, infections and diseases such as: spinal cord injury, multiple sclerosis, stroke, herpes zoster, diabetes and cancer. Many of these pain syndromes are difficult to treat, representing a challenge for many neurologists not routinely trained in pain management. Written by an international team of experts in the field, Neuropathic Pain: Causes, Management and Understanding gives readers an in-depth understanding of the multitude of conditions causing neuropathic pain. Epidemiology, clinical diagnosis, pathophysiology, outcome measurement and the best evidence-based management of individual and general neuropathic pain conditions are also described in depth. A unique chapter, written from a patient's viewpoint,...

Peripheral Neuropathy & Neuropathic Pain

Peripheral Neuropathy & Neuropathic Pain
by Gerard Said (Author)

Written by one of the world's leading experts - Professor G rard Said MD FRCP, Dpt de Neurologie, H pital de la Salp tri re, Paris, France Peripheral neuropathy is a common medical condition, the diagnosis of which is often protracted or delayed. It is not always easy to relate a neuropathy to a specific cause. Many people do not receive a full diagnosis, their neuropathy often being described as 'idiopathic' or 'cryptogenic'. It is said that in Europe, one of the most common causes is diabetes mellitus but there are also many other known potential causes. The difficulty of diagnosis, the limited number of treatment options, a perceived lack of knowledge of the subject - except in specialised clinics, the number of which are limited - all add to the difficulties which many neuropathy...

Neuropathic Pain: Mechanisms, Diagnosis and Treatment

Neuropathic Pain: Mechanisms, Diagnosis and Treatment
by Robert H. Dworkin (Author), David M. Simpson (Editor), Justin C. McArthur (Editor)

The incidence of neuropathic pain continues to rise, yet it is an affliction often misdiagnosed or inadequately treated. Although in recent years considerable research has been dedicated to understanding its mechanisms, there have been few advances in treatment. The contributors to this book are internationally renowned leaders in the fields of peripheral neuropathy and neuropathic pain. They discuss clinical approaches to diagnosis and treatment of neuropathic pain, its underlying mechanisms, and strategies for prevention. In addition, chapters cover timely issues, including legal and ethical concerns surrounding pain treatment, the status of clinical trial methods, and educational efforts. Comprehensive yet concise, this book serves as a guide for diagnostic approaches and treatment of...

Pain: Nerves On Fire Changing Neuropathic Pain

Pain: Nerves On Fire Changing Neuropathic Pain
by PsyD, LP, Jay Tracy PA-C (Author), Sydney Kloster (Illustrator), Dar Daily (Illustrator)

Pain, Nerves on Fire, Changing Neuropathic pain

Striking Back : The Trigeminal Neuralgia and Face Pain Handbook

Striking Back : The Trigeminal Neuralgia and Face Pain Handbook
by George Weigel (Author), Kenneth E. Casey (Author)

Published by TNA in 2004 and authored by George Weigel and Kenneth F. Casey, M.D., this handbook is written in layman's terms, describes all aspects of trigeminal neuralgia (TN) and facial pain, and provides vital information and resources for patients, family, friends and healthcare professionals. A must-have guide for every facial pain patient!

Neuropathic Pain (Oxford Pain Management Library)

Neuropathic Pain (Oxford Pain Management Library)
by Michael Bennett (Author)

Neuropathic pain is increasingly recognized as a chronic disabling condition. It is frequently thought of as harder to treat than other pain types, and it often results in a poorer quality of life. Around 30% of adults in the UK alone have some type of chronic pain and some estimates suggest that one in five of these will have symptoms of neuropathic pain.

This second edition of the popular pocketbook has been fully updated to include recent developments in the diagnosis and management of neuropathic pain. It includes new chapters on the clinical assessment of neuropathic pain and the use of screening tools in its diagnosis. This edition also includes a new chapter focusing on neuropathic lower back pain, a newly emerging clinical entity which is thought to be the most prevalent...

Mechanisms and Mediators of Neuropathic Pain (Progress in Inflammation Research)

Mechanisms and Mediators of Neuropathic Pain (Progress in Inflammation Research)
by Annika B. Malmberg (Editor), Sandra R. Chaplan (Editor)

Numerous improvements in our understanding of the mechanisms that underlie neuropathic pain states have come from the development of animal models, most of which involve partial peripheral nerve injury. The animal models have shown that nerve injury initiates a cascade of events resulting in altered neurochemistry and molecular biology of the peripheral neurons, the dorsal root ganglion cell, and changes in neurotransmitter and receptor expression in the dorsal horn of the spinal cord. Moreover, nerve injury produces anatomical changes with functional consequences.
This volume summarises the current understanding of the pathophysiological processes in the peripheral and central nervous system that contribute to the neuropathic pain. It provides a timely review of neuropathic pain...

Chemotherapy-Induced Neuropathic Pain

Chemotherapy-Induced Neuropathic Pain
by Robert B. Raffa (Editor), Richard Langford (Editor), Joseph V. Pergolizzi Jr. (Editor), Frank Porreca (Editor), Ronald J. Tallarida (Editor)

There have been tremendous recent advances in the pharmacotherapy, dose regimens, and combinations used to treat cancer and for the treatment or prevention of the spread of disease. As a direct result of these advances, there are an increasing number of cancer survivors, although research dealing with chemotherapy-induced pain is still in its early years. Written for pain management specialists, oncologists, pharmacologists, students, and primary care practitioners, Chemotherapy-Induced Neuropathic Pain provides insight into the important area of chemotherapy-induced neuropathic pain. It reviews the basic and clinical research into the normal physiology of pain transmission pathways, neuropathic pain pathology, the chemotherapeutic drug mechanisms of action and adverse effects,...

Pain Relief for Joint Muscle and Nerve Pain: Drug Free Using TENS

Pain Relief for Joint Muscle and Nerve Pain: Drug Free Using TENS
by Robert P Rumball (Author)

Do you need Pain Relief for Muscular, Joint or Nerve Pain, but want a Drug-free remedy? Or Have you tried TENS treatment previously and been disappointed with the results? TENS (Transcutaneous Electrical Nerve Stimulation) Treatment promises so much relief for the sufferer of Chronic and/or Acute Pain, yet so often fails to deliver. The reason for failure is usually either:- The wrong type of TENS. Some TENS units have pre-set programmes which are simple to use, but lack the flexibility to treat the many different types of pain. Incorrect Electrode Placements. Most User Manuals that come with the TENS are basic, with very little real information relating to the accurate placing of electrodes. Incorrect TENS settings. Most manuals only supply...

Emerging Strategies for the Treatment of Neuropathic Pain

Emerging Strategies for the Treatment of Neuropathic Pain
by James N.Campbell (Author), Allan I. Basbaum (Author), André Dray (Author), Ronald Dubner (Author), Robert H. Dworkin (Author), Christine N. Sang (Author), Allan I. Basbaum (Editor), André Dray (Editor), Ronald Dubner (Editor), Robert H. Dworkin (Editor), Christine N. Sang (Editor), James N. Campbell (Editor)

Neuropathic pain is notoriously difficult to treat. Despite an explosion of research in recent years, few new treatments have made their way into the clinic. Why is progress so glacially slow? Where are the new and promising treat­­ments? When will there be a breakthrough in understanding? To address these questions, the editors convened a unique meeting, bringing together leaders from academia and industry. No time was taken up in lectures: all the meeting time was spent in intensive discussions, and this book is the result. It contains the latest available information and provides a blueprint to meet the challenges that lie ahead. It will be invaluable both to clinicians treating neuropathic pain and to researchers studying this difficult but important problem.

© 2017